Medipost Co. Ltd. | |
Stock Exchange | Korea Exchange |
EPS |
KRW742 |
Market Cap |
KRW786.84 B |
Shares Outstanding |
7.87 M |
Public Float |
7.17 M |
Address |
21 Daewangpangyo-ro 644 beon-gil Seongnam GY 13494 Korea, Republic Of |
Employees | - |
Website | http://www.medi-post.co.kr |
Updated | 09/14/2018 |
Medipost Co., Ltd. engages in the development and manufacture of stem cell biotechnology products. It operates through the following business divisions: Cord Blood Bank, Stem Cell Therapy, Health Functional Food, Import and Distribution of Natural Cosmetics and Healthcare Services. The Cord Blood Bank division is involved in collecting and storing stem cells from the newborn's umbilical cord. |